...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Biogen vs. Resverlogix, CTAD December 5

To start the day, Biogen will present Aducanumab Phase 3 results at 8am Pacific with a live webcast. Biogen will also hold an investor Q&A call at 2pm Pacific.

Will be interesting what the market reads on Biogen immediately after their presentation and how it compares to RVX.  data, data and patiently waiting, waiting.  Hopefully December will be a better month for all of us.


 

 

 

 

 

.

Share
New Message
Please login to post a reply